↓ Skip to main content

3D CRISPR screen in prostate cancer cells reveals PARP inhibitor sensitization through TBL1XR1-SMC3 interaction

Overview of attention for article published in Frontiers in oncology, November 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (56th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
3D CRISPR screen in prostate cancer cells reveals PARP inhibitor sensitization through TBL1XR1-SMC3 interaction
Published in
Frontiers in oncology, November 2022
DOI 10.3389/fonc.2022.999302
Pubmed ID
Authors

Huan Zhang, Huanyao Gao, Yayun Gu, August John, Lixuan Wei, Minhong Huang, Jia Yu, Adeyemi A. Adeosun, Richard M. Weinshilboum, Liewei Wang

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 6 40%
Researcher 3 20%
Student > Ph. D. Student 2 13%
Other 1 7%
Unknown 3 20%
Readers by discipline Count As %
Unspecified 6 40%
Biochemistry, Genetics and Molecular Biology 3 20%
Agricultural and Biological Sciences 2 13%
Engineering 1 7%
Unknown 3 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 December 2022.
All research outputs
#15,437,886
of 26,179,695 outputs
Outputs from Frontiers in oncology
#4,328
of 22,919 outputs
Outputs of similar age
#209,559
of 498,472 outputs
Outputs of similar age from Frontiers in oncology
#270
of 1,505 outputs
Altmetric has tracked 26,179,695 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,919 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 498,472 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.
We're also able to compare this research output to 1,505 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.